Senator Investment Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-150,000
| Closed | -$15.5M | – | 48 |
|
|
2022
Q4 | $15.5M | Sell |
150,000
-500,000
| -77% | -$51.7M | 1.4% | 23 |
|
|
2022
Q3 | $55.1M | Sell |
650,000
-200,000
| -24% | -$17M | 5.01% | 3 |
|
|
2022
Q2 | $70.4M | Buy |
+850,000
| New | +$70.4M | 5.04% | 3 |
|
|
2018
Q3 | – | Sell |
-1,000,000
| Closed | -$94.2M | – | 39 |
|
|
2018
Q2 | $94.2M | Buy |
+1,000,000
| New | +$94.2M | 0.94% | 30 |
|
|
2017
Q4 | – | Sell |
-700,000
| Closed | -$65.1M | – | 49 |
|
|
2017
Q3 | $65.1M | Buy |
+700,000
| New | +$65.1M | 0.87% | 32 |
|
|
2017
Q2 | – | Sell |
-800,000
| Closed | -$70.2M | – | 55 |
|
|
2017
Q1 | $70.2M | Hold |
800,000
| – | – | 0.86% | 33 |
|
|
2016
Q4 | $66.3M | Sell |
800,000
-50,000
| -6% | -$4.14M | 1.01% | 26 |
|
|
2016
Q3 | $78.6M | Buy |
850,000
+200,000
| +31% | +$18.5M | 1.04% | 29 |
|
|
2016
Q2 | $50.6M | Buy |
650,000
+150,000
| +30% | +$11.7M | 0.81% | 35 |
|
|
2016
Q1 | $41.2M | Buy |
+500,000
| New | +$41.2M | 0.54% | 40 |
|